Lattice_grid_med
Powered by LatticeGrid

Search Enter term and hit return. Use '*' for as a wildcard.

Publication Listing for the MeSH term outcomes. Found 36 abstracts

no pagination
Dong Y, Zaorsky NG, Li T, Churilla TM, Viterbo R, Sobczak ML, Smaldone MC, Chen DY, Uzzo RG, Hallman MA, Horwitz EM. Effects of interruptions of external beam radiation therapy on outcomes in patients with prostate cancer. Journal of medical imaging and radiation oncology. 2018 Feb;62(1):116-21.   PMCID: PMC5800942
Haifler M, Ristau BT, Higgins AM, Smaldone MC, Kutikov A, Zisman A, Uzzo RG. External Validation of Contact Surface Area as a Predictor of Postoperative Renal Function in Patients Undergoing Partial Nephrectomy. J Urol. 2018 Mar;199(3):649-54.
Moten AS, Zhao H, Wu H, Farma JM. Malignant granular cell tumor: Clinical features and long-term survival. Journal of surgical oncology. 2018 Nov;118(6):891-7.
Waingankar N, Esnaola NF, Uzzo RG. A structured framework for optimizing surgical quality through process-of-care trials. Urol Oncol. 2017 May;35(5):177-9.
Waingankar N, Mallin K, Smaldone M, Egleston BL, Higgins A, Winchester DP, Uzzo RG, Kutikov A. Assessing the relative influence of hospital and surgeon volume on short-term mortality after radical cystectomy. BJU international. 2017 Aug;120(2):239-45.
Williams SB, Huo J, Chamie K, Smaldone MC, Kosarek CD, Fang JE, Ynalvez L, Kim SP, Hoffman KE, Giordano SH, Chapin BF. Discerning the survival advantage among patients with prostate cancer who undergo radical prostatectomy or radiotherapy: The limitations of cancer registry data. Cancer. 2017 May;123(9):1617-24.   PMCID: PMC5897905
Williams SB, Huo J, Chamie K, Smaldone MC, Kosarek CD, Fang JE, Ynalvez LM, Kim SP, Hoffman KE, Giordano SH, Chapin BF. Discerning the survival advantage among patients with prostate cancer who undergo radical prostatectomy or radiotherapy: The limitations of cancer registry data. Cancer. 2017 Jan 18;.
Geynisman DM, Handorf E, Wong YN, Doyle J, Plimack ER, Horwitz EM, Canter DJ, Uzzo RG, Kutikov A, Smaldone MC. Advanced small cell carcinoma of the bladder: clinical characteristics, treatment patterns and outcomes in 960 patients and comparison with urothelial carcinoma. Cancer medicine. 2016 Feb;5(2):192-9.   PMCID: 4735777
Ristau BT, Cahn D, Uzzo RG, Chapin BF, Smaldone MC. The role of radical prostatectomy in high-risk localized, node-positive and metastatic prostate cancer. Future Oncol. 2016 Mar;12(5):687-99.   PMCID: Review
Tomaszewski JJ, Smaldone MC, Uzzo RG, Kutikov A. Is radical nephrectomy a legitimate therapeutic option in patients with renal masses amenable to nephron-sparing surgery?. BJU Int. 2015 Mar;115(3):357-63.
Tomaszewski JJ, Smaldone MC, Uzzo RG, Kutikov A. Is radical nephrectomy a legitimate therapeutic option in patients with renal masses amenable to nephron-sparing surgery?. BJU international. 2015 Mar;115(3):357-63.
Kim SP, Gross CP, Nguyen PY, Smaldone MC, Thompson RH, Shah ND, Kutikov A, Han LC, Karnes RJ, Ziegenfuss JY, Tilburt JC. Specialty bias in treatment recommendations and quality of life among radiation oncologists and urologists for localized prostate cancer. Prostate Cancer and Prostatic Diseases. 2014 Jun;17(2):163-9.   PMCID: No NIH funding
Kim SP, Karnes RJ, Nguyen PL, Ziegenfuss JY, Thompson RH, Han LC, Shah ND, Smaldone MC, Gross CP, Frank I, Weight CJ, Beebe TJ, Tilburt JC. A national survey of radiation oncologists and urologists on recommendations of prostate-specific antigen screening for prostate cancer. BJU international. 2014 May;113(5B):E106-E111.
Agochukwu NQ, Metwalli AR, Kutikov A, Pinto PA, Linehan WM, Bratslavsky G. Economic Burden of Repeat Renal Surgery on Solitary Kidney-Do the Ends Justify the Means? A Cost Analysis. Journal of Urology. 2012 Nov;188(5):1695-700.   PMCID: PMC 3817487
Crispen PL, Soljic A, Stewart G, Kutikov A, Davenport D, Uzzo RG. Enhancing Renal Tumors in Patients with Prior Normal Abdominal Imaging: Further Insight into the Natural History of Renal Cell Carcinoma. Journal of Urology. 2012 Oct;188(4):1089-93.   PMCID: PMC 3815634
Kutikov A, Cooperberg MR, Paciorek AT, Uzzo RG, Carroll PR, Boorjian SA. Evaluating prostate cancer mortality and competing risks of death in patients with localized prostate cancer using a comprehensive nomogram. Prostate Cancer and Prostatic Diseases. 2012 Dec;15(4):374-9.   PMCID: Not NIH fund
Lin NU, Vanderplas A, Hughes ME, Theriault RL, Edge SB, Wong YN, Blayney DW, Niland JC, Winer EP, Weeks JC. Clinicopathologic Features, Patterns of Recurrence, and Survival Among Women With Triple-Negative Breast Cancer in the National Comprehensive Cancer Network. Cancer. 2012 Nov;118(22):5463-72.   PMCID: PMC 36116559
Long CJ, Canter DJ, Smaldone MC, Li TY, Simhan J, Rozenfeld B, Teper E, Chen DY, Greenberg RE, Viterbo R, Uzzo RG, Kutikov A. Role of tumor location in selecting patients for percutaneous versus surgical cryoablation of renal masses. Canadian Journal of Urology. 2012 Oct;19(5):6417-22.
Lubbe W, Cohen R, Sharma N, Ruth K, Peters R, Li JS, Buyyounouski M, Kutikov A, Chen D, Uzzo R, Horwitz E. Biochemical and clinical experience with real-time intraoperatively planned permanent prostate brachytherapy. Brachytherapy. 2012 May;11(3):209-13.
Reyes JM, Canter DJ, Sirohi M, Simhan J, Smaldone MC, Teper E, Kutikov A, Chen DY, Uzzo RG. Delayed proximal ureteric stricture formation after complex partial nephrectomy. BJU international. 2012 Feb;109(4):539-43.
The above publications are sorted by year, faculty last name, and first author. Click on any highlighted author listed to find all publications attributed to that individual. Click on the publication title to see the abstract. First authors who are faculty are highlighted like this. Last authors who are faculty are highlighted like this. Other authors who are faculty are highlighted like this.

MeSH cloud from publications including the MeSH term outcomes

outcomes prostate cancer radical nephrectomy partial nephrectomy surgery survival radical prostatectomy kidney cancer quality nephron-sparing surgery treatments survey risk prostatectomy RESPONSE RATES tumors utilization Urology & Nephrology life expectancy care delivery dialysis patients institution randomized trials seed implantation complications SERVICES TASK-FORCE quality of life masses Male MEN growth adverse effects Surgeons renal cell Female comorbidity t1b RECURRENCE cancer TRIAL active surveillance cystectomy cryoablation process-of-care trials process measures molecular open partial nephrectomy Propensity Score subtypes Oncology DEFINITION Cystectomy granular cell tumor (GCT) Adult epidemiology feasibility Clinical Competence lesions SOCIETY Middle Aged free survival radiation therapy i-125 brachytherapy chronic kidney-disease proximal ureteric stricture 80 and over Aged MANAGEMENT OUTCOMES High-Volume Hospitals beliefs mathematical concepts quality-of-life mortality publication Proportional Hazards Models Registries Young Adult screening Randomized Controlled Trials as Topic models hemodialysis treatment patterns clinical-practice GUIDELINE androgen-deprivation therapy treatment recommendations parenchymal volume men Treatment Outcome postmenopausal women FOLLOW-UP esrd patients RADICAL PROSTATECTOMY methods urothelial carcinoma Urinary Bladder Neoplasms integrated systems statistics & numerical data MORTALITY Kidney Neoplasms neoplasm recurrence kidney-local-nephrectomy-reoperation-costs and cost analysis Adolescent regionalization TRENDS Brachytherapy Prostate cancer-Implant-Small-volume prostate size population external-beam radiotherapy carcinoma LOW-RISK phenotype renal-cell carcinoma radiotherapy nephrectomy disease parameter cytoreductive surgery Nephrectomy basal treatment interruption access basal-like triple-negative-breast cancer-outcomes-brain metastases-obesity-race growth-factor-i cm risk-factors watchful waiting kidney neoplasms-disease progression bladder cell carcinoma radiation therapy radical prostatectomy-nomogram-competing risks-comorbidities candidates renal mass cryoablation-percutaneous-laparoscopic-tumor location Bladder cancer management Hospital Mortality SURVIVORS Aged score Organ Sparing Treatments theoretical kidney malignant volume single-center experience small cell bladder cancer laparoscopic brain metastases prostate-specific antigen
Last updated on Tuesday, April 02, 2019